已收盤 05-08 16:00:00 美东时间
+0.250
+0.35%
Foreign materials stocks are showing impressive gains and potential, with every stock on the top 10 Quant Rankings list carrying a score above 4.0, meaning the system sees a Buy or Strong Buy case acr...
05-06 20:50
今日重点评级关注:Piper Sandler:维持Aclaris Therapeutics"超配"评级,目标价从7美元升至11美元;Evercore ISI集团:维持BioMarin Pharmaceutical"跑赢大市"评级,目标价从110美元升至120美元
05-06 11:29
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从28美元升至49美元;HC Wainwright & Co.:维持Fate Therapeutics"买入"评级,目标价从5美元升至7美元
05-05 11:40
RBC Capital analyst Arun Viswanathan maintains LyondellBasell Industries (NYSE:LYB) with a Outperform and raises the price target from $91 to $94.
05-04 23:49
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据LyondellBasell业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **第一季度核心财务表现:** - EBITDA达到6.15亿美元,同比增长近50% - 每股收益0.49美元(基于非GAAP调整后业务基础) - 现金余额26亿美元,可用流动性73亿美元 - 资本支出2.69亿美元 - 经营活动现金消耗2.69亿美元 - 股息支付2.24亿美元 **各业务板块EBITDA表现:** - 烯烃和聚烯烃-美洲:3.27亿美元,环比翻倍增长 - 中间体和衍生品:2.24亿美元,环比上升 - 先进聚合物解决方案:5800万美元,同比
05-02 12:13
华盛资讯5月2日讯,利安德巴塞尔公司公布2026财年Q1业绩,公司Q1营收71.97亿美元,同比下降6.3%,归母净利润1.23亿美元,同比下滑29.7%。
05-02 00:47
华盛资讯5月1日讯,利安德巴塞尔公司公布2026财年Q1业绩,公司Q1营收71.97亿美元,同比下降6.3%,归母净利润1.25亿美元,同比下滑29.4%。
05-01 21:33
LYB CEO warns Middle East conflict is "steepening" the global cost curve. Read how LyondellBasell is filling supply gaps amid high oil prices.
05-01 19:35
Companies Reporting Before The Bell • WisdomTree (NYSE:WT) is projected to repo...
05-01 19:11
LyondellBasell Industries (NYSE:LYB) reported quarterly earnings of $0.49 per share which beat the analyst consensus estimate of $0.20 by 145 percent. This is a 48.48 percent increase over earnings of $0.33 per share
05-01 18:33